STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, GMED, and MASI
Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry.
STERIS vs.
STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, community ranking, dividends, earnings, analyst recommendations, valuation and risk.
Becton, Dickinson and Company received 263 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.34% of users gave Becton, Dickinson and Company an outperform vote while only 59.19% of users gave STERIS an outperform vote.
STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 1.8%. STERIS pays out 48.4% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has raised its dividend for 20 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
In the previous week, Becton, Dickinson and Company had 23 more articles in the media than STERIS. MarketBeat recorded 44 mentions for Becton, Dickinson and Company and 21 mentions for STERIS. STERIS's average media sentiment score of 1.54 beat Becton, Dickinson and Company's score of 1.34 indicating that STERIS is being referred to more favorably in the media.
94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
STERIS has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500.
STERIS currently has a consensus price target of $258.75, indicating a potential upside of 15.33%. Becton, Dickinson and Company has a consensus price target of $278.29, indicating a potential upside of 21.65%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and Company is more favorable than STERIS.
STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.
Summary
Becton, Dickinson and Company beats STERIS on 12 of the 21 factors compared between the two stocks.
Get STERIS News Delivered to You Automatically
Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:STE) was last updated on 3/28/2025 by MarketBeat.com Staff